Drug Evaluations: Drug Evaluation Anti-infectives: Activity and role of lamivudine in the treatment of adults with human immunodeficiency virus type 1 infection: A review

This publication has 15 references indexed in Scilit:

• Alterations in the Immune Response of Human Immunodeficiency Virus (HIV)-Infected Subjects Treated with an HIV-Specific Protease Inhibitor, Ritonavir
  The Journal of Infectious Diseases, 1996
• Lamivudine or Stavudine in Two- and Three-Drug Combinations against Human Immunodeficiency Virus Type 1 Replication In Vitro
  The Journal of Infectious Diseases, 1996
• Genotypic and phenotypic characterization of HIV-1 isolated from patients receiving (−)-2′,3′-dideoxy-3′-thiacytidine
  Antiviral Research, 1995
• Hair loss associated with lamivudine
  The Lancet, 1994
• Natural Occurrence of Drug Resistance Mutations in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 Isolates
  AIDS Research and Human Retroviruses, 1994
• The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine
  Antimicrobial Agents and Chemotherapy, 1993
• Effects of (-)-2'-deoxy-3'-thiacytidine (3TC) 5'-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gamma
  Antimicrobial Agents and Chemotherapy, 1992
• Cellular metabolism of (−) enantiomeric 2′-deoxy-3′-thiacytidine
  Biochemical Pharmacology, 1992
• Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria.
  Journal of Clinical Investigation, 1992
• The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro
  Antimicrobial Agents and Chemotherapy, 1992